There is not a specific warning in the product label against alcohol (ethanol) consumption with Biktarvy, a medication used for HIV treatment. But drinking too much alcohol can damage your liver. Ask your doctor if it is safe for you to drink alcohol while taking Biktarvy.
Before you start treatment with Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide), tell your doctor if you have liver problems, including hepatitis B virus (HBV) infection or a history of alcohol abuse. Excessive alcohol use can lead to liver disease and cirrhosis, which may affect your treatment. The use of Biktarvy is not recommended in patients with severe liver disease.
Severe liver problems, including a worsening of hepatitis B virus (HBV) infection, can also occur with Biktarvy treatment. If you have HBV infection and take Biktarvy, your HBV may get worse if you stop taking Biktarvy. Do not stop your Biktarvy treatment or change your dose without first talking to your healthcare provider.
Specific symptoms you may notice if you have a liver problem includes:
- skin or the white part of your eyes turns yellow
- dark “tea-colored” urine
- light-colored stools
- loss of appetite for several days or longer
- nausea (upset stomach)
- pain in your stomach area
Tell your healthcare provider right away if you get any of these symptoms.
It is important not to miss any doses of your medication. Use caution if drinking may affect your ability to remember your dose of Biktarvy.
Learn More: Biktarvy Drug Interactions (in more detail)
This is not all the information you need to know about Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Biktarvy information here, and discuss this information and any questions you have with your doctor or other health care provider.